Literature DB >> 21030528

Detection of clonality in follicular lymphoma using formalin-fixed, paraffin-embedded tissue samples and BIOMED-2 immunoglobulin primers.

Ellen Berget1, Lars Helgeland, Anders Molven, Olav Karsten Vintermyr.   

Abstract

AIMS: The BIOMED-2 multiplex PCR protocol is a commonly used procedure for assessing B cell clonality in lymphoma diagnostics. Follicular lymphoma poses a special challenge for PCR-based analyses because of high prevalence of somatic hypermutations in the rearranged immunoglobulin (IG) domains. This study aimed to evaluate the BIOMED-2 protocol performance in detection of B cell clonality in follicular lymphoma using formalin-fixed, paraffin-embedded (FFPE) tissue.
METHODS: FFPE samples from 118 patients diagnosed with follicular lymphoma in the period 1998-2008 were used in the study. Clonality of IG heavy (IGH) and light chains (IGK, IGL) was assessed using a PCR procedure that was optimised for FFPE tissue.
RESULTS: The highest clonal detection rates were 67.8% with the IGH Vн-FR2-Jн assay and 66.1% with the IGK Vκ-Jκ assay. Clonality was detected in 94.9% of all FFPE follicular lymphoma samples when all assays were combined. FFPE samples stored for 1-5 years did not perform significantly differently from those stored for 6-11 years. Interobserver agreement of clonality was tested for all analyses. The lowest score (Cohen's κ value = 0.56) was observed for the IGK Vκ-Jκ clonality assay.
CONCLUSIONS: An improved PCR protocol for detection of clonality in FFPE samples using BIOMED-2 IG primers is presented. For best performance, a combination of IGH and IGK analyses is recommended.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030528     DOI: 10.1136/jcp.2010.081109

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Evaluation diagnostic usefulness of immunoglobulin light chains (Igκ, Igλ) and incomplete IGH D-J clonal gene rearrangements in patients with B-cell non-Hodgkin lymphomas using BIOMED-2 protocol.

Authors:  S Ghorbian; I Jahanzad; G R Javadi; E Sakhinia
Journal:  Clin Transl Oncol       Date:  2014-05-27       Impact factor: 3.405

2.  Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma.

Authors:  Qingyan Liu; Itziar Salaverria; Stefania Pittaluga; Armin G Jegalian; Liqiang Xi; Reiner Siebert; Mark Raffeld; Stephen M Hewitt; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2013-03       Impact factor: 6.394

3.  Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report.

Authors:  Charalampos Tzoulis; Thomas Schwarzlmüller; Ivar Otto Gjerde; Eirik Søfteland; Gesche Neckelmann; Martin Biermann; Julien Haroche; Oddbjørn Straume; Olav Karsten Vintermyr
Journal:  BMC Res Notes       Date:  2015-04-30

4.  Prognostic value of bone marrow involvement by clonal immunoglobulin gene rearrangements in follicular lymphoma.

Authors:  Ellen Berget; Lars Helgeland; Knut Liseth; Turid Løkeland; Anders Molven; Olav Karsten Vintermyr
Journal:  J Clin Pathol       Date:  2014-09-18       Impact factor: 3.411

5.  Diagnostic value of immunoglobulin κ light chain gene rearrangement analysis in B-cell lymphomas.

Authors:  Ira Kokovic; Barbara Jezersek Novakovic; Srdjan Novakovic
Journal:  Int J Oncol       Date:  2014-12-09       Impact factor: 5.650

6.  Experience with the BIOMED-2 standardized polymerase chain reaction protocol for immunoglobulin and T- cell receptor clonality analysis in the Instituto Nacional de Cancerología, Colombia

Authors:  Nicolás Villamizar-Rivera; Natalia Olaya
Journal:  Biomedica       Date:  2022-05-01       Impact factor: 1.173

7.  Clonality analysis of lymphoid proliferations using the BIOMED-2 clonality assays: a single institution experience.

Authors:  Ira Kokovic; Barbara Jezersek Novakovic; Petra Cerkovnik; Srdjan Novakovic
Journal:  Radiol Oncol       Date:  2014-04-25       Impact factor: 2.991

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.